Upregulation of Monocyte Proinflammatory Cytokine Production by C-Reactive Protein is Significantly Related to Ongoing Myocardial Damage and Future Cardiac Events in Patients With Chronic Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 7, 2010, Pages 562-571

  Nakagomi, Akihiro ^a   Seino, Yoshihiko ^b   Endoh, Yasumi ^a   Kusama, Yoshiki ^a   Atarashi, Hirotsugu ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

C reactive protein; cytokines; heart failure; Troponin T

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HEART FAILURE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGED; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIUM; UP-REGULATION;

EID: 77953727170     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.02.003     Document Type: Article

References (34)

1. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84 (1999) 608-611
2. Setsuta K., Seino Y., Ogawa T., Arao M., Miyatake Y., and Takano T. Use of cytosolic and myofibril damage in patients with chronic heart failure. Am J Med 113 (2002) 717-722
3. Torre Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the SOLVD study. J Am Coll Cardiol 27 (1996) 1201-1206
4. Katz S.D., Rao R., Berman J.W., Schwarz M., Demopoulos L., Bijou R., and Lejemtel T.H. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 90 (1994) 12-16
5. Kubota T., McTiernan C.F., Frye C.S., Slawson S.E., Lemster B.H., Koretsky A.P., et al. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-alpha. Circ Rec 81 (1997) 627-635
6. Anand I.S., Latini R., Florea V.G., Kuskowski M.A., Rector T., Masson S., et al., for the Val-HeFT Investigators. C-reactive protein in heart failure. Prognostic value and the effects of Valsartan. Circulation 112 (2005) 1428-1434
7. Berton G., Cordiano R., Palmieri R., Sigismondo P., Pagliara V., and Palatini P. C-reactive protein in acute myocardial infarction: Association with heart failure. Am Heart J 145 (2003) 1094-1101
8. Ballou S.P., and Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (1992) 361-368
9. Hirasawa Y., Nakagomi A., Kobayashi Y., Katoh T., and Mizuo K. Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia. Circ J 73 (2009) 639-646
10. Nakagomi A., Freedman S.B., and Gezcy C.L. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein. Relationship with age, sex, and hormone replacement treatment. Circulation 101 (2000) 1785-1791
11. Mann D.L. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100 (1999) 999-1008
12. Parissis J.T., Filippatos G., Nikolaou V., and Adamopoulos S. Cytokines and anti-cytokine therapeutic approaches to chronic heart failure. Eur J Heart Fail 13 (2002) 356-364
13. Mann D.L. Inflammatory mediators and the failing heart. Past, present, and the foreseeable future. Circ Res 91 (2002) 988-998
14. Tsutsui H., Kinugawa S., and Matsushima S. Oxidative stress and mitochondrial DNA damage in heart failure. Circ J Suppl A (2008) A31-A37
15. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
16. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
17. Pepys M.B., and Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34 (1983) 141-212 [review]
18. Kunshner I., Broder M.L., and Karp D. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61 (1978) 235-242
19. Filippatos G.S., Gangopadhyay N., Lalude O., et al. Regulation of apoptosis by vasoactive peptides. Am J Physiol 281 (2001) L749-L761
20. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
21. Deswal A., Peterson N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trail (VEST). Circulation 103 (2001) 2055-2059
22. Setsuta K., Seino Y., Ogawa T., Ohtsuka T., Seimiya K., and Takano T. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circ J 68 (2004) 747-750
23. Yokoyama T., Nakano M., Bednarczyk J.L., McIntyre B.W., Entman M.L., and Mann D.L. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95 (1997) 1247-1252
24. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., et al. Tumor necrosis factor α-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
25. Sivasubramanian N., Coker M.L., Kurrelmeyer K.M., MacLellan W.R., DeMayo F.J., Spinale F.G., et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104 (2001) 826-831
26. Li Y.Y., Feng Y.Q., Kadokami T., McTiernan C.F., Draviam R., Watkins S.C., et al. Myocardial extracellular remodeling in mice overexpressing tumor necrosis factor α can be modulated by anti-tumor necrosis factor α therapy. Proc Natl Acad Sci U S A 97 (2000) 12746-12751
27. Mold C., Gresham H.D., and Du Clos T.W. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs. J Immunol 166 (2001) 1200-1205
28. Mold C., Gewurz H., and Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 42 (1999) 23-30
29. Gershov D., Kim S., Brot N., and Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192 (2000) 1353-1364
30. Ratnam S., and Mookerjeas S. The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein. Immunology 94 (1998) 560-568
31. Gullestad L., Pal A., Ueland T., Espevik T., Yee G., Vagelos R., et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 34 (1999) 2061-2067
32. Tsutamoto T., Wada A., Maeda K., Mabuchi N., Hayashi M., Tsutsui T., et al. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patents with chronic heart failure. J Am Coll Cardiol 35 (2000) 714-721
33. Ohtsuka T., Hamada M., Hiasa G., Sasaki O., Suzuki M., Hara Y., et al. Effects of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37 (2001) 412-417
34. Ferro D., Parrotto S., Basili S., Alesasndri C., and Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 36 (2000) 427-431